Press release
Investigation announced for Investors in shares of MEI Pharma, Inc. (NASDAQ: MEIP) over possible Violations of Securities Laws
An investigation for investors in MEI Pharma, Inc. (NASDAQ: MEIP) shares over potential securities laws violations by MEI Pharma.
Investors who purchased shares of MEI Pharma, Inc. (NASDAQ: MEIP), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by MEI Pharma, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
San Diego, CA based MEI Pharma, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. MEI Pharma, Inc. Reported that its Total Revenue rose from $40.69 million for the 12 months period that ended on June 30, 2022, to $48.81 million for the 12 months period that ended on June 30, 2023, and that its net Loss over those respective time periods declined from $54.45 million to $31.83 million.
Shares of MEI Pharma, Inc. (NASDAQ: MEIP) declined from $7.97 per share on May 23, 2023, to as low as $4.55 per share on January 22, 2023.
Those who purchased shares of MEI Pharma, Inc. (NASDAQ: MEIP) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of MEI Pharma, Inc. (NASDAQ: MEIP) over possible Violations of Securities Laws here
News-ID: 3363554 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for MEI
Minnesota Elevator, Inc. (MEI) Acquires Interstate Elevator
June 15, 2022 - Minnesota Elevator, Inc. (MEI) one of Midwest largest independent union elevator contractors, announced that it has acquired Interstate Elevator based in Topeka, Kansas. Interstate Elevator provides elevator Maintenance, Repairs and Modernization services.
Interstate Elevator has what MEI President, Rick Lowenberg, calls a "very good fit for our Kansas Missouri division. The equipment will be serviced by seasoned mechanics in the area Interstate serves today."
Working together with MEI…
MEI Wet Processing Announces MEI East Location
ALBANY, OREGON (February 14, 2019) — MEI Wet Processing, LLC., a leading provider of application services and solutions for high tech industries such as: LED, Wireless, Power, MEMS, WLP, Data Storage, Logic markets, Solar, Military and Aerospace, announces the opening of their second location, MEI Wet Processing East.
The 10,600 sq. ft. facility, located at 7042 Snowdrift Rd., Allentown, PA 18106 features Batch Spray and Immersion technology research & development and…
MEI Debuts Cloud-based Workflow System
Jenkintown, PA (February 11, 2014) — Managing Editor Inc. (MEI), a leading provider of digital publishing and workflow solutions, today announced the release of TruEdit®, its latest collaborative workflow system. TruEdit is a cloud-based platform for planning, creating, managing and delivering multi-channel content via its web client and Adobe InDesign® Plug-in. Additionally, TruEdit comes equipped with powerful automations for streamlined output to the Adobe Digital Publishing Suite™ (DPS), enhancing the…
MEI Helps Us Weekly Publish iPad App
Jenkintown, PA (May 22, 2012) — Managing Editor Inc. (MEI) today announced that it provided the production software behind the brand-new Us Weekly iPad app, now available in the iTunes store. Wenner Media, publisher of Us Weekly and other entertainment magazines including Rolling Stone, is producing the app with the vjoon K4™ Cross-Media Publishing Platform integrated with the Adobe® Digital Publishing Suite™. To streamline the iPad app-productions process, MEI developed…
MEI Updates IPS for Enhanced Performance
Jenkintown, PA (July 21, 2009) — Managing Editor Inc. (MEI), an Adobe premier development partner and a leading provider of software solutions for the publishing industry, today announced the release of the Integrated Production Suite 4.6, the latest version of the powerful collection of MEI products for enterprise publishers.
Thanks to these updates, users of IPS 4.6 will enjoy improved performance and compatibility with the latest versions of design applications.
…
MEI, eMerge Sign Co-Marketing Agreement
Jenkintown, PA (May 5, 2009) — Managing Editor Inc. (MEI), an Adobe premier development partner and a leading provider of software solutions for the publishing industry, today announced a joint effort with eMerge Consulting to market and support integration between the vjoon K4 Publishing System and Scriba™ XML workflow engine.
MEI is the exclusive distributor of K4, the leading editorial workflow system for Adobe® InDesign® and Adobe InCopy®, in the Americas.…
